ECOG-ACRIN NHLBI-MDS

Primary Category:

Cancer Control and Prevention Protocols

Disease Category:

Leukemia, Myelodysplastic Syndrome

Status:

Temporarily Closed

The National Myelodysplastic Syndromes (MDS) Study

 

NCT#02775383

Eligible for screening study DCP 001

This protocol has additional regulatory requirements to be completed prior to registering any patients at your site.  Please contact Amber Boerner at 406-969-6067 or aboerner@mtcancer.org for additional information.

To help protect the safety and welfare of human subject participants and research staff during the COVID-19 epidemic, enrollment of new participants on NHLBI-MDS is suspended effective immediately, 03/27/20, until further notice, and all follow-up research sample collection and shipment should be discontinued.